Study Purpose: To determine whether gabapentin, a widely prescribed generic calcium channel/γ-aminobutyric acid-modulating medication, increases rates of sustained abstinence and abstinence from heavy drinking and reduces alcohol-related insomnia, dysphoria, and craving in a dose-dependent manner. Design, Participants, and Setting: A 12-week, double-blind, placebo-controlled, randomized dose-ranging study of 150 men and women aged 18 years and…
